Clinicopathological features of lung adenocarcinoma with KRAS mutations.

@article{Kakegawa2011ClinicopathologicalFO,
  title={Clinicopathological features of lung adenocarcinoma with KRAS mutations.},
  author={Seiichi Kakegawa and Kimihiro Shimizu and Masayuki Sugano and Yohei Miyamae and Kyoichi Kaira and Takuya Araki and Tetsuhiro Nakano and Mitsuhiro Kamiyoshihara and Osamu Kawashima and Izumi Takeyoshi},
  journal={Cancer},
  year={2011},
  volume={117 18},
  pages={4257-66}
}
BACKGROUND KRAS and epidermal growth factor receptor (EGFR) mutations are thought to play an important role in the carcinogenesis of lung adenocarcinoma. However, clinicopathological findings of KRAS mutated adenocarcinoma cases have not yet been fully clarified. The authors analyzed the relationship between the KRAS mutation and corresponding… CONTINUE READING